Home  »  Business   »  Is Agenus Inc. (NASDAQ: AGEN) A Good Investment Fo...

Is Agenus Inc. (NASDAQ: AGEN) A Good Investment For New Investors Now?

Agenus Inc. (NASDAQ:AGEN) shares, rose in value on Thursday, 12/08/22, with the stock price up by 1.62% to the previous day’s close as strong demand from buyers drove the stock to $2.51.

Actively observing the price movement in the last trading, the stock closed the session at $2.47, falling within a range of $2.43 and $2.60. The value of beta (5-year monthly) was 1.25. Referring to stock’s 52-week performance, its high was $3.62, and the low was $1.25. On the whole, AGEN has fluctuated by 12.56% over the past month.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

With the market capitalization of Agenus Inc. currently standing at about $631.82 million, investors are eagerly awaiting this quarter’s results, scheduled for Feb 27, 2023 – Mar 03, 2023. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.19, which is expected to increase to -$0.07 for fiscal year -$0.73 and then to about -$0.64 by fiscal year 2023. Data indicates that the EPS growth is expected to be -563.60% in 2023, while the next year’s EPS growth is forecast to be 12.30%.

Analysts have estimated the company’s revenue for the quarter at $20.69 million, with a low estimate of $10 million and a high estimate of $27.5 million. According to the average forecast, sales growth in current quarter could jump down -91.80%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2023, the company’s y-o-y revenues would reach $93.97 million, representing a decrease of -68.20% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that AGEN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 25% Buy while long term indicators on average have been pointing out that it is a 50% Buy.

5 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The stock is rated as a Hold by 0 analyst(s), 5 recommend it as a Buy and 0 called the AGEN stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Buy.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of AGEN currently trading nearly -10.10% and -3.57% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.43, while the 7-day volatility ratio is showing 9.68% which for the 30-day chart, stands at 8.88%. Furthermore, Agenus Inc. (AGEN)’s beta value is 1.30, and its average true range (ATR) is 0.22. The company’s stock has been forecasted to trade at an average price of $6.83 over the course of the next 52 weeks, with a low of $5.00 and a high of $8.30. Based on these price targets, the low is -99.2% off current price, whereas the price has to move -230.68% to reach the yearly target high. Additionally, analysts’ median price of $7.00 is likely to be welcomed by investors because it represents a decrease of -178.88% from the current levels.

A comparison of Agenus Inc. (AGEN) with its peers suggests the former has fared considerably weaker in the market. AGEN showed an intraday change of 1.62% in last session, and over the past year, it shrunk by -24.40%%. In comparison, Johnson & Johnson (JNJ) has moved higher at 0.02% on the day and was up 7.83% over the past 12 months. On the other hand, the price of Bristol-Myers Squibb Company (BMY) has fallen -0.06% on the day. The stock, however, is off 38.68% from where it was a year ago. Other than that, the overall performance of the S&P 500 during the last trading session shows that it gained 0.75%. Meanwhile, the Dow Jones Industrial Improved by 0.55%.

Data on historical trading for Agenus Inc. (NASDAQ:AGEN) indicates that the trading volumes over the past 10 days have averaged 3.53 million and over the past 3 months, they’ve averaged 4.76 million. According to company’s latest data on outstanding shares, there are 286.85 million shares outstanding.

Nearly 9.64% of Agenus Inc.’s shares belong to company insiders and institutional investors own 59.60% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 18.6 million shares as on Oct 13, 2022, resulting in a short ratio of 3.68. According to the data, the short interest in Agenus Inc. (AGEN) stood at 6.57% of shares outstanding as of Oct 13, 2022; the number of short shares registered in Sep 14, 2022 reached 16.12 million. The stock has fallen by -22.05% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGEN stock heading into the next quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

5 Lithium Stocks with High Future Potential

Demand for lithium is expected to increase 8-fold by 2030. The world's largest automakers are racing to go green as the global EV boom continues.

 

We have collated a list of top five lithium stocks which are well positioned to benefit from the 2023 lithium boom because of their focus on multiple high-potential lithium projects.

100% free. stop anytime no spam